We have taken bold steps to shape the landscape in inflammatory bowel disease (IBD) management, striving to help patients achieve a better tomorrow. But we have more work to do. We are relentless in our quest to better understand patient needs and will continue to work closely with patients and partners to advance the quality of care in IBD.
Learn more about our gastroenterology focus areas:
A chronic inflammatory bowel disease characterized by inflammation of any part of the gastrointestinal tract. Symptoms vary from person to person and often fluctuate between active flare-ups and remission.
Characterized by inflammation of the large intestine, ulcerative colitis is a chronic inflammatory bowel disease. Symptoms range from mild to severe but may make it difficult to keep to a usual routine.
TNF-α
A cytokine that contributes to the induction and maintenance of the inflammatory immune response.
IL-23
A cytokine that shares a subunit with IL-12 and works to mediate inflammatory responses.
JAK1
An enzyme that signals and initiates the response of other cytokines involved in the body’s immune response.
CD40
A protein receptor expressed by B cells, macrophages and dendritic cells that is involved in mediating inflammatory responses.
